Renpei Kato

610 total citations
64 papers, 412 citations indexed

About

Renpei Kato is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Renpei Kato has authored 64 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 26 papers in Surgery. Recurrent topics in Renpei Kato's work include Renal cell carcinoma treatment (27 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Bladder and Urothelial Cancer Treatments (20 papers). Renpei Kato is often cited by papers focused on Renal cell carcinoma treatment (27 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Bladder and Urothelial Cancer Treatments (20 papers). Renpei Kato collaborates with scholars based in Japan, United States and South Korea. Renpei Kato's co-authors include Wataru Obara, Yoichiro Kato, Ryo Takata, Mitsugu Kanehira, Daiki Ikarashi, Shigekatsu Maekawa, Tamotsu Sugai, Toyomasa Katagiri, Tomoaki Fujioka and Yusuke Nakamura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The Journal of Urology.

In The Last Decade

Renpei Kato

55 papers receiving 410 citations

Peers

Renpei Kato

PRM

ONCOL

SURGE

IMMUN

Yoichiro Kato Japan

Joe Chin Canada

Rupesh I. Bhatt United Kingdom

Güneş Güner United States

Yu Ishizuya Japan

Dennis Peters Netherlands

Juan Pinelli United States

Marie‐Aude Lefrère‐Belda France

Guillermo de Velasco Spain

Ana B. Galván Spain

Yoichiro Kato Japan

Renpei Kato

168 ×0.9

PRM

187 ×1.0

ONCOL

133 ×0.9

163 ×1.2

SURGE

91 ×1.0

IMMUN

Citations per year, relative to Renpei Kato Renpei Kato (= 1×) peers Yoichiro Kato

Countries citing papers authored by Renpei Kato

Since Specialization

Citations

This map shows the geographic impact of Renpei Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renpei Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renpei Kato more than expected).

Fields of papers citing papers by Renpei Kato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renpei Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renpei Kato. The network helps show where Renpei Kato may publish in the future.

Co-authorship network of co-authors of Renpei Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Renpei Kato. A scholar is included among the top collaborators of Renpei Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renpei Kato. Renpei Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ikarashi, Daiki, et al.. (2025). Tumor-shrinking effects of enfortumab vedotin between primary urothelial carcinoma and metastatic organs. Frontiers in Oncology. 14. 1493922–1493922. 1 indexed citations

Kato, Renpei. (2025). Selection of Optimal Neoadjuvant Therapy Before Cytoreductive Nephrectomy and Its Biomarker in Renal Cell Carcinoma. SHILAP Revista de lepidopterología. 23(1). 38–46.

Abé, Masakazu, Shigekatsu Maekawa, Akiko Yashima‐Abo, et al.. (2024). The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder Cancer. Journal of Molecular Diagnostics. 26(4). 278–291. 4 indexed citations

Ikarashi, Daiki, Shigekatsu Maekawa, Renpei Kato, et al.. (2024). Changes in Renal Function After Nephroureterectomy for Upper Tract Urothelial Cancer in Elderly Patients. Cureus. 16(6). e61479–e61479. 1 indexed citations

Ikarashi, Daiki, Shigehisa Kitano, Makiko Yamashita, et al.. (2024). Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer. Scientific Reports. 14(1). 1442–1442. 1 indexed citations

Ikarashi, Daiki, et al.. (2024). Successful treatment of eosinophilia associated with dialysis‐related renal cancer with radical nephrectomy. IJU Case Reports. 7(4). 301–304.

Abé, Masakazu, Noriyuki Sasaki, Akiko Yashima‐Abo, et al.. (2023). Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma. Cancer Science. 115(2). 529–539. 11 indexed citations

Kato, Yoichiro, Renpei Kato, Shigekatsu Maekawa, et al.. (2022). 後腹膜に発生した気管支原性嚢胞. Kyoto University Research Information Repository (Kyoto University). 1 indexed citations

Kato, Renpei, Sei Naito, Kazuyuki Numakura, et al.. (2022). Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study. International Journal of Clinical Oncology. 27(3). 563–573. 8 indexed citations

10.

Kato, Renpei, Shigekatsu Maekawa, Yoichiro Kato, et al.. (2022). A case of male perineal aggressive angiomyxoma with expressions of female hormone receptors. IJU Case Reports. 5(4). 308–311. 1 indexed citations

11.

Ikarashi, Daiki, Naoki Yanagawa, Masamichi Suzuki, et al.. (2022). Pathological Complete Response to Preoperative Nivolumab Plus Cabozantinib for Renal Cell Carcinoma With Inferior Vena Cava Thrombus: A Case Report. Cancer Diagnosis & Prognosis. 3(1). 124–129. 5 indexed citations

12.

Takata, Ryo, Mitsugu Kanehira, Yoichiro Kato, et al.. (2021). Improvement of three-dimensional motion sickness using a virtual reality simulator for robot-assisted surgery in undergraduate medical students: A prospective observational study. BMC Medical Education. 21(1). 498–498. 8 indexed citations

13.

Hatakeyama, Shingo, Sei Naito, Kazuyuki Numakura, et al.. (2021). External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study. Urologic Oncology Seminars and Original Investigations. 39(12). 836.e11–836.e17. 7 indexed citations

14.

Naito, Sei, Tomoyuki Kato, Kazuyuki Numakura, et al.. (2021). Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era. International Journal of Clinical Oncology. 26(10). 1947–1954. 4 indexed citations

15.

Kato, Renpei, Hiroaki Itamochi, Shigekatsu Maekawa, et al.. (2020). Rapid progression of recurrent disease in a patient with renal cell carcinoma with vaginal metastasis. SHILAP Revista de lepidopterología. 3(5). 185–188. 5 indexed citations

16.

Kato, Renpei, Daiki Ikarashi, Shigekatsu Maekawa, et al.. (2020). Analyses of Nivolumab Exposure and Clinical Safety Between 3-mg/kg Dosing and 240-mg Flat Dosing in Asian Patients with Advanced Renal Cell Carcinoma in the Real-World Clinical Setting. Translational Oncology. 13(6). 100771–100771. 4 indexed citations

17.

Hatakeyama, Shingo, Sei Naito, Kazuyuki Numakura, et al.. (2020). Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective study. International Journal of Urology. 28(4). 369–375. 10 indexed citations

18.

Ikarashi, Daiki, Yoichiro Kato, Mitsugu Kanehira, et al.. (2018). Appropriate preoperative membranous urethral length predicts recovery of urinary continence after robot-assisted laparoscopic prostatectomy. World Journal of Surgical Oncology. 16(1). 224–224. 21 indexed citations

19.

Kato, Renpei, et al.. (2017). Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma. BMC Cancer. 17(1). 214–214. 8 indexed citations

20.

Obara, Wataru, Takashi Karashima, Kazuyoshi Takeda, et al.. (2016). Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma. Cancer Immunology Immunotherapy. 66(1). 17–24. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact